Skip to main content

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Feb 3, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
57
−3 vs. Q3 2022
Portfolio value
$141.6M
−$445.0K (−0.3%) vs. Q3 2022
Filed
Feb 3, 2023
SEC
Holdings of Birchview Capital, LP in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
BMYBristol Myers Squibb CoStock727,785$52.4M37.0%00.0%UnchangedHistory
BDSXBiodesix IncCOM5,039,633$11.6M8.2%+2,669,562+112.6%AddedHistory
NBIXNeurocrine Biosciences IncStock84,240$10.1M7.1%−1,000−1.2%ReducedHistory
PRTAProthena Corp Public Ltd CoSHS127,195$7.66M5.4%+8,250+6.9%AddedHistory
ELUTElutia Inc.CL A COM1,515,184$6.44M4.5%+97,061+6.8%AddedHistory
QDELQuidelOrtho CorpCOM61,306$5.25M3.7%00.0%UnchangedHistory
OVVOvintiv Inc.COM84,200$4.27M3.0%00.0%UnchangedHistory
UTHRUnited Therapeutics CorpCOM15,000$4.17M2.9%00.0%UnchangedHistory
ACADAcadia Pharmaceuticals IncCOM249,400$3.97M2.8%00.0%UnchangedHistory
PHRPhreesia, Inc.COM82,700$2.68M1.9%00.0%UnchangedHistory
HROWHarrow, Inc.COM180,000$2.66M1.9%00.0%UnchangedHistory
ALBOAlbireo Pharma, Inc.COM117,000$2.53M1.8%00.0%UnchangedHistory
MASIMasimo CorpCOM15,280$2.26M1.6%00.0%UnchangedHistory
INBXInhibrx Biosciences, Inc.COM70,448$1.74M1.2%00.0%UnchangedHistory
FHTXFoghorn Therapeutics Inc.COM264,843$1.69M1.2%00.0%UnchangedHistory
AXDXAccelerate Diagnostics, IncCOM2,252,388$1.59M1.1%00.0%UnchangedHistory
AVEOAveo Pharmaceuticals, Inc.COM NEW100,000$1.50M1.1%−40,000−28.6%ReducedHistory
ALKSAlkermes plc.SHS50,000$1.31M0.9%00.0%UnchangedHistory
CYTKCytokinetics IncCOM NEW25,000$1.15M0.8%00.0%UnchangedHistory
ATECAlphatec Holdings, Inc.COM NEW90,000$1.11M0.8%+80,000+800.0%AddedHistory
CORTCorcept Therapeutics IncCOM50,000$1.02M0.7%00.0%UnchangedHistory
KPTIKaryopharm Therapeutics Inc.COM291,332$991.0K0.7%+22,000+8.2%AddedHistory
ETRNMidstream Co LLCCOM133,050$891.0K0.6%00.0%UnchangedHistory
PXDPioneer Natural Resources CoCOM3,800$868.0K0.6%00.0%UnchangedHistory
DCGODocGo Inc.COM110,000$778.0K0.5%00.0%UnchangedHistory
IMGNImmunoGen, Inc.COM150,000$744.0K0.5%00.0%UnchangedHistory
VTYXVentyx Biosciences, Inc.COM22,000$721.0K0.5%−23,000−51.1%ReducedHistory
BLUEbluebird bio, Inc.COM98,000$678.0K0.5%00.0%UnchangedHistory
APLSApellis Pharmaceuticals, Inc.COM12,000$621.0K0.4%00.0%UnchangedHistory
HALOHalozyme Therapeutics, Inc.COM10,000$569.0K0.4%+10,000NewHistory
TSVT2seventy bio, Inc.COMMON STOCK59,833$561.0K0.4%00.0%UnchangedHistory
ISEEIVERIC bio, Inc.COM25,000$535.0K0.4%00.0%UnchangedHistory
SILKSilk Road Medical IncCOM10,000$529.0K0.4%00.0%UnchangedHistory
ARVNArvinas, Inc.COM15,000$513.0K0.4%00.0%UnchangedHistory
SLNOSoleno Therapeutics IncCOM245,127$485.0K0.3%00.0%UnchangedHistory
KNSAKiniksa Pharmaceuticals International, plcCOM CL A30,000$449.0K0.3%00.0%UnchangedHistory
PTGXProtagonist Therapeutics, IncCOM38,000$415.0K0.3%00.0%UnchangedHistory
XENEXenon Pharmaceuticals Inc.COM10,000$394.0K0.3%00.0%UnchangedHistory
TXG10x Genomics, Inc.CL A COM10,000$364.0K0.3%+10,000NewHistory
FOLDAmicus Therapeutics, Inc.COM28,000$342.0K0.2%−10,000−26.3%ReducedHistory
KROSKeros Therapeutics, Inc.COM7,000$336.0K0.2%+7,000NewHistory
SRPTSarepta Therapeutics, Inc.COM2,500$324.0K0.2%00.0%UnchangedHistory
XNCRXencor IncCOM12,300$320.0K0.2%00.0%UnchangedHistory
KALVKalVista Pharmaceuticals, Inc.COM40,000$270.0K0.2%00.0%UnchangedHistory
NKTRNektar TherapeuticsCOM118,000$267.0K0.2%−10,000−7.8%ReducedHistory
CGEMCullinan Therapeutics, Inc.COM25,114$265.0K0.2%00.0%UnchangedHistory
BCRXBiocryst Pharmaceuticals IncCOM20,000$230.0K0.2%00.0%UnchangedHistory
GTHXG1 Therapeutics, Inc.COM40,000$217.0K0.2%00.0%UnchangedHistory
IFRXInflaRx N.V.COM70,000$217.0K0.2%00.0%UnchangedHistory
GOSSGossamer Bio, Inc.COM99,088$215.0K0.2%−60,000−37.7%ReducedHistory
STOKStoke Therapeutics, Inc.COM15,000$138.0K0.1%00.0%UnchangedHistory
CNCEConcert Pharmaceuticals, Inc.COM20,000$117.0K0.1%00.0%UnchangedHistory
BHVNBiohaven Ltd.COM7,365$102.0K0.1%−7,365−50.0%ReducedHistory
ELTXElicio Therapeutics, Inc.COM54,392$44.0K<0.1%00.0%UnchangedHistory
YTENYIELD10 Bioscience, Inc.COM18,750$31.0K<0.1%00.0%UnchangedHistory
AWHLAspira Women's Health Inc.COM60,070$20.0K<0.1%00.0%UnchangedHistory
SIENProject Sage Oldco, Inc.COM40,000$8.00K<0.1%00.0%UnchangedHistory

Sold out since Q3 2022 (6)

Positions held at the end of Q3 2022 that are gone from this filing.

Positions of Birchview Capital, LP sold out since Q3 2022
SecurityClassShares in Q3 2022Value in Q3 2022% of portfolio in Q3 2022History
CLRContinental Resources, IncCOM38,600$2.58M1.8%History
ChemoCentryx, Inc.16383L106COM20,000$1.03M0.7%–
NARIInari Medical, Inc.Stock10,000$726.0K0.5%History
IRTCiRhythm Holdings, Inc.COM4,000$501.0K0.4%History
LSFLaird Superfood, Inc.COM STK28,000$51.0K<0.1%History
CFRXCONTRAFECT CorpCOM200,000$34.0K<0.1%History